The global lysosomal storage disease treatment market was valued at USD 4.54 billion in 2024 and is expected to grow to USD 6.68 billion by 2033, with a projected compound annual growth rate (CAGR) of 4.54% over 2025–2033. This growth is fueled by improvements in diagnostic capabilities, increasing awareness of rare genetic disorders, and ongoing advancements in therapies such as enzyme...